Literature DB >> 12746783

Pneumocystis jiroveci genotypes and primary infection.

Anne Totet1, Nieves Respaldiza, Jean-Claude Pautard, Christian Raccurt, Gilles Nevez.   

Abstract

This study describes the molecular typing of Pneumocystis jiroveci organisms from 5 nonpremature immunocompetent infants who developed a primary infection. Four P. jiroveci internal transcribed spacer (ITS) types were identified. All have been previously described in reports concerning immunosuppressed adults with pneumocystosis. Present data suggest that identical types can be implicated either in first contact or in additional contacts between fungus and host and that both immunocompetent infants and immunocompromised patients may be part of a common human reservoir for the fungus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746783     DOI: 10.1086/374844

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.

Authors:  Kerry M Empey; Melissa Hollifield; Kevin Schuer; Francis Gigliotti; Beth A Garvy
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

2.  Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice.

Authors:  Kerry M Empey; Melissa Hollifield; Beth A Garvy
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

Review 3.  Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-06

4.  Pneumocystis primary infection in infancy: Additional French data and review of the literature.

Authors:  Gilles Nevez; Thibaud Guillaud-Saumur; Pierrick Cros; Nicolas Papon; Sophie Vallet; Dorothée Quinio; Adissa Minoui-Tran; Léa Pilorgé; Loïc de Parscau; Jacques Sizun; Theresa J Ochoa; Beatriz Bustamante; Carolina Ponce; Sergio L Vargas; Solène Le Gal
Journal:  Med Mycol       Date:  2020-02-01       Impact factor: 4.076

Review 5.  Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Rheumatology (Oxford)       Date:  2012-09-22       Impact factor: 7.580

Review 6.  Pneumocystis jirovecii in Patients With Cystic Fibrosis: A Review.

Authors:  Pierre Bonnet; Solène Le Gal; Enrique Calderon; Laurence Delhaes; Dorothée Quinio; Florence Robert-Gangneux; Sophie Ramel; Gilles Nevez
Journal:  Front Cell Infect Microbiol       Date:  2020-09-29       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.